Response to Dr SD Mundle
Leukemia ( We agree with Dr Mundle that the precise role of the stroma in the pathophysiology of myelodysplasia remains uncertain. However, we think that our data on the effect of normal and MDS stroma on model haemopoietic stem/progenitor cells (HPC), although open to different interpretations, show more than 'marginal' effects. We have used a model that can demonstrate interactions between stromal cells and haemopoietic cells over a relatively short time, unlike previous studies using more prolonged 2-stage Dexter co-cultures, [1] [2] [3] where precise effects on proliferation and survival are difficult to separate. Our central finding is that after 72 h co-culture, F-36P cell numbers increase by a similar amount (approximately 60%) with normal and MDS stromal layers, whereas standardized apoptotic ratios were significantly increased on MDS compared with normal stroma (mean 1.4 ± 0.5). This leads us to suggest that while the ability of MDS stroma to support HPC proliferation appears intact, stromal regulation of HPC survival may be deficient in MDS. Indeed, given the similar increases in F-36P numbers at 72 h, one could argue that the proliferative drive on MDS stroma may be greater than on normal stroma: increased apoptosis on MDS adherent layers might be accompanied by a compensatory increase in the proliferation of sub-populations of F-36P cells that are resistant to the 'apoptotic stimuli'.
Due to limitations of cell numbers, our co-cultures were analysed at only two time-points (4 h and 72 h), and thus our data do not take into account possible changes in kinetics of F-36P cells (including exchange between the non-adherent and adherent compartments) between 4 and 72 h. We therefore agree that it remains to be determined whether the apparent stromal defect in MDS results from a decrease in stromal proliferative stimuli with time, eg reduced GM-CSF/IL-3 levels at 72 h in MDS stromal co-cultures, or from an excess of pro-apoptotic signals despite optimal levels of growth factors within the in vitro stromal microenvironment. The first hypothesis might be explored in dye-tracking experiments comparing proliferation of F-36P cells in the presence of rh-GM-CSF/IL-3, and in contact cultures with stroma. The latter hypothesis is at least plausible given the recent studies of the IL-3-dependent cell line TF-1 on LS801, an SV-40 transformed MDS stromal cell line: 4 pro-survival signals and induce cell death. A role for TNF-␣ in the pathogenesis of MDS has previously been suggested, 5 and despite the lack of diffusible TNF-␣ in F-36P MDS stromal co-cultures in our studies, a role for this cytokine in inducing apoptosis in F-36P cells cannot be excluded without quantifying levels within the adherent layers. Furthermore, it remains possible that stromal induction of apoptosis in MDS might be mediated by alternative, or hitherto unidentified cytokines.
Although our data do not identify the precise nature of the stromal 'defect' in MDS, they have generated a number of hypotheses that can be assessed further using the model of haemopoiesis we have described.
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